Educational Tools

General

• Axial spondyloarthritis: is there a treatment of choice?
• What Is Axial Spondyloarthritis (AxSpA)?
• Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis
• Recommendations for the Treatment of Ankylosing Spondylitis

Rheumatoid Arthritis (RA)

• FDA Information on Biosimilars (for Patients)
• FDA Information on Biosimilars (for Healthcare Professionals)
• FDA Biosimilarity Guidance
• The Purple Book for Biosimilars
• 2015 ACR Guideline for the Treatment of RA
• RA Overview (for Patients)
• RA Treatment (for Patients)
• RA: Early Intervention
• Review: Biologics Discontinuation
• Biologic-free Remission in Established RA
• Understanding Biologics and Biosimilars
• 2010 RA Classification Criteria
• Synovial Phenotypes and Response to Biologics
• The role of CTLA-4 in the regulation of T cell immune responses
• EULAR Recommendations 2013 Update: Management of RA
• Improving Cardiovascular Risk Screening in Patients with RA
• ACR Rheumatoid Arthritis Fact Sheet
• RA Drug Guide: Analgesics, Steroids, Biologics, DMARDs, NSAIDs
• Arthritis Foundation
• Understanding RA and Coping with the Disease - Patient Handout
• RA and the Microbiome
• Microbiome: RA Trigger?

Vasculitis

• ANCA-associated Vasculitis: Systemic Symptoms
• ANCA-associated Vasculitis: Minimal Evaluation of All Patients